Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast. J of Skin [Internet]. 2025 Jul. 23 [cited 2025 Oct. 2];9(4):s587. Available from: https://skin.dermsquared.com/skin/article/view/3494